Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    

ARIAD PHARMACEUTICALS, INC.
Mes dernières consult.
Most popular
Report
 SummaryNewsCompany 
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
More about the company
Latest news on ARIAD PHARMACEUTICALS, INC
02/18 ARIAD PHARMACEUTICALS : Medinol Announces Appointment Of Harvey J. Berger, M.D.,..
02/18 TAKEDA PHARMACEUTICAL : Japans Takeda acquires US cancer drug manufacturer ARIAD..
02/16 ARIAD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Completi..
02/16 ARIAD PHARMACEUTICALS : Announces Submission of Marketing Authorization Applicat..
02/06 ARIAD PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (for..
02/06 LAWSUIT FOR INVESTORS AGAINST ACQUIS : ARIA) Filed
02/06 ARIAD PHARMACEUTICALS : Announces Submission of Marketing Authorization Applicat..
02/03 ARIAD PHARMACEUTICALS : Enters into Definitive Agreement to Be Acquired by Taked..
02/03 ARIAD PHARMACEUTICALS : Takeda to Acquire ARIAD Pharmaceuticals, Inc.
01/26 TAKEDA PHARMACEUTICAL : Commences Cash Tender Offer for All Outstanding Shares o..
More news
Sector news : Bio Therapeutic Drugs
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
11/01DJAs Experimental Treatments Grow, Families Face Tough Choices
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/30 3 THINGS IN BIOTECH YOU SHOULD LEARN : April 30, 2017
04/18 SNIPPET ROUNDUP : Aerie Stumbles On Safety; Stada Is Sold At Last
04/11 First-Quarter Deal Making Shows Glimmers Of Growth
03/31 WHAT TO WATCH IN Q2 : Upcoming Healthcare Regulatory Events
03/07 Roche Looks Ready To Rule Another Cancer Niche
Managers
NameTitle
Christophe M. Bianchi President
Timothy P. Clackson CSO, President-Research & Development
Nicholas Ventresca Chief Information Officer & Senior Vice President
Liza Heapes Associate Director-Corporate Communications
David C. Dalgarno Vice President-Research Technologies
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS, INC.0
GILEAD SCIENCES1.16%94 601
REGENERON PHARMACEUTICALS6.67%42 072
VERTEX PHARMACEUTICALS100.10%37 280
GENMAB4.43%11 878
EXELIXIS, INC.76.93%7 805